Connection

Marco Massari to Prospective Studies

Back to Details
This is a "connection" page, showing publications Marco Massari has written about Prospective Studies.
Marco Massari
Connection Strength
0.048
Prospective Studies
  1. Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1215-1222.
    View in: PubMed
    Score: 0.009
  2. Accuracy of CT in a cohort of symptomatic patients with suspected COVID-19 pneumonia during the outbreak peak in Italy. Eur Radiol. 2020 Dec; 30(12):6818-6827.
    View in: PubMed
    Score: 0.009
  3. The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort. Dig Liver Dis. 2019 03; 51(3):438-442.
    View in: PubMed
    Score: 0.008
  4. Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network. PLoS One. 2017; 12(10):e0185728.
    View in: PubMed
    Score: 0.007
  5. What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group. Infez Med. 2017 Jun 01; 25(2):150-157.
    View in: PubMed
    Score: 0.007
  6. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study. PLoS One. 2017; 12(2):e0172159.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.